Association Between Severe Gastrointestinal Toxicity and Molecular Targeted Therapy in Patients Received Radiotherapy for Metastatic Bone Tumor or Myeloma

International Journal of Radiation Oncology Biology Physics - Netherlands
doi 10.1016/j.ijrobp.2019.06.163
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Severe Gastrointestinal Hemorrhage During Targeted Therapy for Advanced Breast Carcinoma

Current Oncology
Oncology
2014English

Initial Report of the Genitourinary and Gastrointestinal Toxicity of Post-Prostatectomy Proton Therapy for Prostate Cancer Patients Undergoing Adjuvant or Salvage Radiotherapy

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2018English

Molecular Markers in Gastrointestinal Cancer: Targeted Therapy and Tailored Chemotherapy

Oncology Research and Treatment
Cancer ResearchOncologyHematology
2004English

Stromal Targeted Therapy in Bone Metastatic Prostate Cancer: Promise Delivered

Asian Journal of Andrology
MedicineUrology
2011English

Molecular Subtyping of Metastatic Renal Cell Carcinoma: Implications for Targeted Therapy

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2014English

Radiotherapy, Bisphosphonates and Surgical Stabilization of Complete or Impending Pathologic Fractures in Patients With Metastatic Bone Disease

Journal of Cancer
Oncology
2016English

Bone-Targeted Therapy in Metastatic Breast Cancer - All Well-Established Knowledge?

Breast Care
SurgeryOncology
2014English

The Economic Burden of Gastrointestinal Stromal Tumor (GIST) Recurrence in Patients Who Have Received Adjuvant Imatinib Therapy

Journal of Medical Economics
Health Policy
2014English

Mitochondria-Targeted Therapy for Metastatic Melanoma

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy